Alkermes
today agenda value creation innovation growth and profitability blair executive vice president and chief operating officer alkermes new model optimizing for success executive vice president and chief medical officer focus on innovative molecular design senior vice president research oncology alfa clinical data updates vice president clinical research oncology alfa preclinical research heather senior director research oncology tumor targeted split fusion protein josh principal scientist research oncology selective inhibitors senior vice president research receptor agonists senior director research project leadership and strategy a | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
10 of 144
Related slides by other companies
Theravance Biopharma
Results
February 2023
a session | Theravance Biopharma
Theravance Biopharma
Investor Conference
April 2023
a session | Theravance Biopharma
AstraZeneca
Investor Day
March 2021
new near term opportunities | AstraZeneca
ValueAct Capital
Activist
February 2022
inside directors interests conflict with a strategy to transform | ValueAct Capital
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io